ADC Therapeutics SA
ADCT
$3.43
-$0.05-1.44%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 8.58% | 9.64% | 21.31% | 20.92% | 34.07% |
| Total Depreciation and Amortization | -58.89% | -53.17% | -33.51% | -15.21% | -14.61% |
| Total Amortization of Deferred Charges | 214.24% | 101.77% | -52.76% | -67.43% | -78.06% |
| Total Other Non-Cash Items | -22.31% | -9.83% | -50.92% | -52.17% | -64.01% |
| Change in Net Operating Assets | 94.64% | -762.70% | -723.79% | 152.36% | -1,197.15% |
| Cash from Operations | 15.82% | -14.00% | 1.28% | 12.34% | 7.68% |
| Capital Expenditure | 94.67% | 69.55% | 67.93% | 63.20% | 78.03% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 204.50% | 145.56% | 67.93% | 63.20% | 78.03% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 54.12% | 54.05% | -4.75% | -5.09% | 13,944.11% |
| Repurchase of Common Stock | -21.45% | 16.16% | -83.07% | -229,100.00% | -204,100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 54.78% | 55.53% | -5.54% | -7.39% | 31.38% |
| Foreign Exchange rate Adjustments | 14.88% | 467.47% | -103.16% | 8,966.67% | 132.69% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 191.72% | 137.76% | -9.41% | 24.97% | 48.09% |